Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Dayer

Showing results (141-150 of 163) with videos related to

Pageof 17
Sort By:
Pharmacogenetics|January 26, 1999
Role of glutathione S-transferase GSTM1, GSTM3, GSTP1 and GSTT1 genotypes in modulating susceptibility to smoking-related lung cancerN Jourenkova-Mironova, H Wikman, C Bouchardy, et al.
International Journal of Cancer|March 17, 1999
Glutathione S-transferase GSTM1, GSTM3, GSTP1 and GSTT1 genotypes and the risk of smoking-related oral and pharyngeal cancersN Jourenkova-Mironova, A Voho, C Bouchardy, et al.
Pulmonary Pharmacology & Therapeutics|April 2, 1999
Function of human alveolar macrophages after a 3-day course of azithromycin in healthy volunteersJ D Aubert, L Juillerat-Jeanneret, P Fioroni, et al.
Pharmacogenetics|September 10, 1998
N-acetyltransferase NAT1 and NAT2 genotypes and lung cancer riskC Bouchardy, K Mitrunen, H Wikman, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 1, 1986
The molecular mechanisms of two common polymorphisms of drug oxidation--evidence for functional changes in cytochrome P-450 isozymes catalysing bufuralol and mephenytoin oxidationU A Meyer, J Gut, T Kronbach, et al.
European Journal of Clinical Pharmacology|January 1, 1986
Importance of oxidative polymorphism and levomepromazine treatment on the steady-state blood concentrations of clomipramine and its major metabolitesA E Balant-Gorgia, L P Balant, C Genet, et al.
Biochemical and Biophysical Research Communications|November 30, 1984
Characterization of a common genetic defect of cytochrome P-450 function (debrisoquine-sparteine type polymorphism)--increased Michaelis is Constant (Km) and loss of stereoselectivity of bufuralol 1'-hydroxylation in poor metabolizersP Dayer, R Gasser, J Gut, et al.
Archiv Fur Psychiatrie Und Nervenkrankheiten|January 1, 1982
Role of oxidation polymorphism on blood and urine concentrations of amitriptyline and its metabolites in manA E Balant-Gorgia, P Schulz, P Dayer, et al.
General Hospital Psychiatry|May 16, 1998
Use of the label "litigation neurosis" in patients with somatoform pain disorderA F Allaz, M Vannotti, J Desmeules, et al.
European Journal of Cancer (Oxford, England : 1990)|September 7, 2000
CYP2D6 gene polymorphism in caucasian smokers: lung cancer susceptibility and phenotype-genotype relationshipsL Laforest, H Wikman, S Benhamou, et al.
Pageof 17

Showing results (141-150 of 163) with videos related to

Sort By:
Pageof 17
Pharmacogenetics|January 26, 1999
Role of glutathione S-transferase GSTM1, GSTM3, GSTP1 and GSTT1 genotypes in modulating susceptibility to smoking-related lung cancerN Jourenkova-Mironova, H Wikman, C Bouchardy, et al.
International Journal of Cancer|March 17, 1999
Glutathione S-transferase GSTM1, GSTM3, GSTP1 and GSTT1 genotypes and the risk of smoking-related oral and pharyngeal cancersN Jourenkova-Mironova, A Voho, C Bouchardy, et al.
Pulmonary Pharmacology & Therapeutics|April 2, 1999
Function of human alveolar macrophages after a 3-day course of azithromycin in healthy volunteersJ D Aubert, L Juillerat-Jeanneret, P Fioroni, et al.
Pharmacogenetics|September 10, 1998
N-acetyltransferase NAT1 and NAT2 genotypes and lung cancer riskC Bouchardy, K Mitrunen, H Wikman, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 1, 1986
The molecular mechanisms of two common polymorphisms of drug oxidation--evidence for functional changes in cytochrome P-450 isozymes catalysing bufuralol and mephenytoin oxidationU A Meyer, J Gut, T Kronbach, et al.
European Journal of Clinical Pharmacology|January 1, 1986
Importance of oxidative polymorphism and levomepromazine treatment on the steady-state blood concentrations of clomipramine and its major metabolitesA E Balant-Gorgia, L P Balant, C Genet, et al.
Biochemical and Biophysical Research Communications|November 30, 1984
Characterization of a common genetic defect of cytochrome P-450 function (debrisoquine-sparteine type polymorphism)--increased Michaelis is Constant (Km) and loss of stereoselectivity of bufuralol 1'-hydroxylation in poor metabolizersP Dayer, R Gasser, J Gut, et al.
Archiv Fur Psychiatrie Und Nervenkrankheiten|January 1, 1982
Role of oxidation polymorphism on blood and urine concentrations of amitriptyline and its metabolites in manA E Balant-Gorgia, P Schulz, P Dayer, et al.
General Hospital Psychiatry|May 16, 1998
Use of the label "litigation neurosis" in patients with somatoform pain disorderA F Allaz, M Vannotti, J Desmeules, et al.
European Journal of Cancer (Oxford, England : 1990)|September 7, 2000
CYP2D6 gene polymorphism in caucasian smokers: lung cancer susceptibility and phenotype-genotype relationshipsL Laforest, H Wikman, S Benhamou, et al.
Pageof 17